Correlation Between Emergent Biosolutions and Viatris

Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Viatris at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Viatris into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Emergent Biosolutions and Viatris, you can compare the effects of market volatilities on Emergent Biosolutions and Viatris and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Viatris. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Viatris.

Diversification Opportunities for Emergent Biosolutions and Viatris

0.46

Correlation Coefficient

Emergent Biosolutions  Viatris

Very weak diversification

The 3 months correlation between Emergent and Viatris is 0.46. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Viatris in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viatris and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Viatris. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viatris has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Viatris go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Viatris

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Viatris. In addition to that, Emergent Biosolutions is 4.23 times more volatile than Viatris. It trades about -0.03 of its total potential returns per unit of risk. Viatris is currently generating about 0.04 per unit of volatility. If you would invest  1,251  in Viatris on September 15, 2024 and sell it today you would earn a total of  12.00  from holding Viatris or generate 0.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Emergent Biosolutions  vs.  Viatris

Emergent Biosolutions

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent fundamental drivers, Emergent Biosolutions unveiled solid returns over the last few months and may actually be approaching a breakup point.

Viatris

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Viatris are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Viatris may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Emergent Biosolutions and Viatris

The main advantage of trading using opposite Emergent Biosolutions and Viatris positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Viatris can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viatris will offset losses from the drop in Viatris' long position.

The idea behind Emergent Biosolutions and Viatris pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.